Biodesix, Inc. (BDSX) - Margin operasi

Simbol lan logo merek Biodesix (BDSX)

The performance of Biodesix, Inc. (BDSX) is driven by Medicare coverage and the implementation of diagnostic protocols within clinics. Marginal income from core operations allows for a real-time assessment of business profitability, where -18.70 determines the current value of the metric. Stable demand for biotechnology provides the company with defensive qualities during a recession, while revenue is based on high-tech blood tests for the early detection of lung cancer.

biodesix.com (BDSX): Rentabilitas dodolan operasi saka 04.07.2022 nganti 19.11.2026

Rincian metrik lan analitis perusahaan biodesix.com (BDSX)

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:Biodesix Corporation, BDSX
Produk dadi Biodesix, Inc.

Biodesix, Inc. (BDSX) is optimizing the express delivery of biomaterials through a network of logistics hubs, which directly supports the efficiency of operational processes in lung cancer diagnostics. This operating profit margin ratio reflects the proportion of earnings before interest and taxes to total revenue, allowing investors to assess the actual profitability of the core business and the volatility of cost management efficiency via the chart's price action.